Tyra Biosciences Income Statement (2020-2026) | TYRA

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
4.38M5.48M7.25M9.64M12.05M10.91M10.40M10.41M12.16M19.27M20.68M17.20M18.00M22.70M22.18M24.96M24.31M25.47M28.19M33.47M
Selling, General & Administrative (Quarter)
1.13M1.15M2.68M5.19M0.19M2.73M4.62M3.93M3.85M4.69M4.96M5.12M5.54M5.91M7.56M6.89M7.14M7.47M8.33M8.53M
Other Operating Expenses (Quarter)
3.19M
Operating Expenses (Quarter)
5.51M6.64M9.93M14.83M15.43M13.64M15.02M14.33M16.01M23.96M25.63M22.32M23.53M28.60M29.74M31.85M31.45M32.94M36.52M42.00M
Operating Income (Quarter)
-5.51M-6.64M-9.93M-14.83M-15.43M-13.64M-15.02M-14.33M-16.01M-23.96M-25.63M-22.32M-23.53M-28.60M-29.74M-31.85M-31.45M-32.94M-36.52M-42.00M
EBIT (Quarter)
-5.51M-6.64M-9.93M-14.83M-15.43M-13.64M-15.02M-14.33M-16.01M-23.96M-25.63M-22.32M-23.53M-28.60M-29.74M-31.85M-31.45M-32.94M-36.52M-42.00M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.00M0.01M0.02M0.35M1.13M2.16M2.45M2.74M2.81M2.80M4.13M4.83M4.59M4.17M3.70M3.35M3.08M2.68M2.69M
Other Non Operating Income (Quarter)
0.01M-0.01M
Non Operating Income (Quarter)
-0.00M-0.01M0.00M0.01M0.33M1.14M2.12M2.45M2.74M2.81M2.80M4.13M4.83M4.59M4.17M3.70M3.35M3.08M2.68M2.69M
Net income details
EBT (Quarter)
-5.60M-44.68M-9.93M-34.75M-15.17M-31.32M-12.96M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Profit After Tax (Quarter)
-5.51M-6.64M-9.93M-14.83M-15.10M-12.51M-12.89M-11.88M-13.27M-21.15M-22.45M-18.19M-18.70M-22.08M-26.55M-28.15M-28.10M-29.86M-33.88M-39.59M
Income from Continuing Operations (Quarter)
-5.60M-44.68M-9.93M-34.75M-15.17M-31.32M-12.96M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Consolidated Net Income (Quarter)
-5.60M-44.68M-9.93M-34.75M-15.17M-31.32M-12.96M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Income towards Parent Company (Quarter)
-5.60M-44.68M-9.93M-34.75M-15.17M-31.32M-12.96M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Net Income towards Common Stockholders (Quarter)
-5.60M-44.68M-9.93M-34.75M-15.17M-31.32M-12.96M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Additional items
EPS (Basic) (Quarter)
-2.47-4.88-0.72-0.84-0.36-0.75-0.31-1.60-1.66-1.43-0.53-1.44-1.18-2.29-0.45-0.70-0.70-1.27-0.57-5.89
EPS (Diluted) (Quarter)
-2.47-4.88-0.72-0.84-0.36-0.75-0.31-1.60-1.66-1.43-0.53-1.44-1.18-2.29-0.45-0.70-0.70-1.27-0.57-5.89
Shares Outstanding (Quarter)
2.27M9.16M13.78M41.55M41.78M42.00M41.88M42.39M42.59M42.87M42.70M52.23M58.67M58.87M57.22M59.34M59.55M59.67M59.60M61.75M
Shares Outstanding (Diluted) (Quarter)
2.27M9.16M13.78M41.55M41.78M42.00M41.88M42.39M42.59M42.87M42.70M52.23M58.67M58.87M57.22M59.34M59.55M59.67M59.60M61.75M
EBITDA (Quarter)
-5.51M-6.64M-9.93M-14.83M-15.43M-13.64M-15.02M-14.33M-16.01M-23.96M-25.63M-22.32M-23.53M-28.60M-29.74M-31.85M-31.45M-32.94M-36.52M-42.00M
Interest Expenses (Quarter)
0.10M38.04M19.94M0.09M18.81M0.10M55.90M57.34M39.98M56.84M50.37M111.00M0.30M13.46M13.80M46.02M0.20M324.43M